Taking Mounjaro and Ramipril Together: What You Need to Know

You've just been prescribed Mounjaro — and you're already on ramipril

The scenario is common. You've been taking ramipril for years, your cardiologist or GP put you on it after a diagnosis of high blood pressure or as heart protection following a cardiovascular event, and now a prescriber has suggested Mounjaro to help manage your weight. Your immediate question is reasonable: will these two medicines cause a problem?

The short answer is that no direct pharmacokinetic interaction between tirzepatide and ramipril has been identified. The NHS's tirzepatide medicines page does not list ACE inhibitors as a contraindicated class. The Mounjaro SmPC, held on the eMC, confirms that tirzepatide has not been shown to interfere with the absorption, distribution, metabolism or elimination of ramipril in any clinically significant way.

The indirect effect, though, deserves real attention. Mounjaro works partly by reducing appetite and slowing gastric emptying, which leads to meaningful weight reduction over weeks and months. Losing even five to ten percent of body weight consistently lowers blood pressure. If your ramipril dose was calibrated at your current, higher weight, the combined effect of the drug and your weight loss may push blood pressure lower than intended. That's not dangerous in itself, but it can cause lightheadedness, tiredness or dizziness, particularly when you stand up quickly. A practical habit worth building: check your blood pressure at a pharmacy or with a home monitor every four weeks during the early months of treatment. A reading takes under a minute and gives you and your GP a clear picture of what's happening.

You can read more about the specific question of co-prescribing in our dedicated page on taking Mounjaro with ramipril.

What your GP needs to know, and why telling them matters

Ramipril is almost always prescribed and monitored by a GP, so your GP is the right person to loop in once you start Mounjaro. NHS England's guidance on weight-management injections explicitly encourages informing your wider healthcare team when starting a GLP-1 medicine, and that includes telling whoever manages your blood pressure.

The conversation is straightforward. Let your GP know you've started tirzepatide, what dose you're on, and ask whether they'd like to schedule a blood-pressure check at your next routine appointment. Most GPs welcome the heads-up. If your blood pressure does drop consistently, they may reduce or pause your ramipril, a positive outcome, not a problem. It simply reflects the fact that your physiology has changed and your prescription needs to keep up with it.

One thing not to do: adjust your ramipril dose yourself because you feel your blood pressure is low. Ramipril is also cardioprotective in ways that are independent of blood pressure, and stopping or reducing it without guidance can carry risk depending on your history. Your prescribers hold the full picture; changes to existing medicines should run through them.

If you're curious how similar questions play out with other ACE inhibitors, the considerations for lisinopril and Mounjaro follow closely the same reasoning.

Symptoms worth knowing about during the first few months

The GI side effects of Mounjaro (nausea, loose stools, reduced appetite, occasional dizziness) are well documented. On their own, they're common, usually mild, and tend to settle as your body adjusts. When you're also on ramipril, a couple of them carry a bit more significance.

Persistent vomiting or diarrhoea can cause dehydration, and dehydration reduces blood volume. That drop in volume, layered on top of an ACE inhibitor's blood-pressure-lowering effect, can occasionally stress the kidneys. If you experience severe, prolonged vomiting or diarrhoea that prevents you drinking normally, contact your GP or call 111 promptly rather than waiting it out.

Dizziness when standing up is another signal to take seriously. It often resolves on its own as the body adapts, but if it's regular or severe, report it to whoever manages your ramipril. The MHRA Yellow Card scheme lets patients report unexpected side effects directly, which helps regulators build a clearer picture of how these medicines interact in real-world use.

For a broader overview of what tirzepatide involves (mechanism, schedule, eligibility) the tirzepatide overview covers the detail. And if you have questions about how treatment fits your particular circumstances, our Mounjaro page, which also links to our Mounjaro podcast where prescribers discuss real patient questions in depth, is a good starting point before booking a consultation.

Who reviews your suitability, and how

At nume, every consultation is read by a GPhC-registered Independent Prescriber. That prescriber reviews your medical history, your current medicines (ramipril included) and your general health picture before deciding whether treatment is clinically suitable. They are not an automated system working through a checklist; they read your answers, consider what they mean together, and make a clinical judgement.

If you're wondering about the cost side of private treatment, our page on Mounjaro pricing in the UK explains what private prescriptions typically include and what to look out for. Mounjaro is a prescription-only medicine; the prescription itself is part of the price at nume, with no separate consultation or delivery fee added on top.

If you're ready to talk through your medications and see whether Mounjaro is right for you alongside your existing treatment, speak to our prescribers, the consultation is free, and you'll hear back the same day.